Alex Day – CEO


Alex Day was born in Louisville, Kentucky and at an early age his family moved to Kalamazoo, Michigan, where his father was a biochemist at the UpJohn Company. Alex had an early passion for science and en-trepreneurism. Alex attended First Assembly Christian School and graduated high school in three years to pursue a degree in physics and astronomy. Alex attended Western Kentucky University where he received a bachelors degree in physics, mathematics and Russian language.


Alex’s 30 year career started with Audax, Inc. a pharmaceutical research and discovery company, where he started as a technical liaison for setting up studies for pharmaceutical companies and worked with Audax for 8 years, eventually leading the companies strategic vision for business development. In 2000, Alex founded Sheltowee LLC and currently serves as the companies CEO. As the founder and CEO of Sheltowee Alex has been a thought leader in life sciences and technology based companies, and the policies that promote the growth of those businesses. Alex founded and served as President of the Kentucky Life Sciences Organization, the predecessor the Kentucky BioAlliance, and also served as the Chairman of the Governor’s Life Sciences Consortium under Governor Ernie Fletcher, where he led a blue ribbon panel and authored a strategic plan for growing the life sciences industry in Kentucky. Alex has also served as the managing partner of the venture capital funds, the Kentucky Natural Products Fund, the Owensboro Emerging Ventures Fund and the Sheltowee Venture Funds I and II. Alex has served on the board of the Kentucky Tobacco Research and Development Center where he was appointed by Governor Paul Patton and served on the Kentucky Science and Technology Corporation’s board.

Alex has experience in a number of technical areas including alternative energy, information technology and diagnostics. Alex drafted a strategic plan for the community of Owensboro, KY that has resulted in over $50 million in investment in the area of plant made pharmaceuticals for that community. Alex also drafted and implemented the business plan for Kentucky BioProcessing, a company that has become the world leader in plant made pharmaceuticals where Alex was instrumental in the development of a vaccine for Ebola. Alex has been involved in the startup of over a dozen technology based companies. He continues to leverage his experience and knowledge to work with com-munities, inventors, scientists and visionaries to help bring exciting new innovations to the marketplace.